You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 12, December 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Letters to the Editor
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Chromosomal Aneuploidy as a Predictor for Poor Outcome in Patients With Head and Neck Cancer

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

It has been well established that the presence of microscopic cancer in surgical margins reduces local control of disease, decreases patient survival, and exposes the patient to additional morbidity if reoperation of the margin is undertaken.1 In a previous study we demonstrated significant levels of chromosome aneuploidy in 10 patients with head and neck squamous cell carcinomas using fluorescence in situ hybridization (FISH) assays.2 There was similar imbalance, although in lower frequency, in clinically normal adjacent mucosa of all patients. We postulated that the detection of aneuploidy by interphase FISH assay enhances the routine histopathological assessment and proposed the use of chromosome instability (CI) as a biomarker for the screening of tumor margins and identification of routine disease. Recently, DNA ploidy has been used to predict risk of oral carcinoma in patients with oral leukoplakia.3

We report our 4-year follow-up of 10 patients in terms of risk for recurrence and . . . [Full Text of this Article]



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Molecular Cytogenetics in Solid Tumors: Laboratorial Tool for Diagnosis, Prognosis, and Therapy
Varella-Garcia
The Oncologist 2003;8:45-58.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.